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Available online 17 November 2008The generation of recombinant single-chain antibodies from either non-immune or immune
phage display antibody libraries is an effectivemeans to obtain high afﬁnity antibodies against a
speciﬁc target. Non-immune libraries contain a wide variety of antibodies but these are often
low afﬁnity. Immune libraries contain a high frequency of high afﬁnity antibodies, but are
typically limited to a single antigen. Due to the VH and VL recombination that occurs during
antibody library construction, we hypothesized that an immune antibody library produced
against one member of a protein family would contain antibodies speciﬁc for other members of
the same protein family. Here, we tested this hypothesis bymining an existing anti-human Toll-
like receptor-2 (hTLR2) antibody library for antibodies speciﬁc for other members of the TLR
family. This procedure, referred to as homolog mining, proved to be effective. Using a cell-based
system to pan and screen the anti-TLR2 library, we identiﬁed single chain antibodies speciﬁc for
three of the four hTLR2 homologs we targeted. The antibodies identiﬁed, anti-murine TLR2,
anti-hTLR5, and anti-hTLR6, bind speciﬁcally to their target, with no cross-reactivity to hTLR2
or other TLRs tested. These results demonstrate that combinatorial re-assortment of VH and VL
fragments from multiple sources during Ab library construction increases Ab repertoire
complexity, allowing antibody libraries produced by immunizationwith one antigen to be used
to obtain antibodies speciﬁc to related antigens. The principle of homolog mining may be
extended to other protein families and will facilitate and accelerate antibody production
processes.







The production of single chain variable fragment (scFv)
antibodies using phage display (McCafferty et al., 1990;
Winter et al., 1994; Marks and Marks, 1996) has several
advantages over traditional hybridoma technologies (Kohlervine serum albumin
ity; scFv, single-chain
TLR, murine toll-like
m, NC 27710, United
nn).
Y-NC-ND license.;andMilstein,1975). First, the number of phage antibodies that
can be generated is much larger than the number of
hybridomas that can be produced in the same period of
time, or from the same number of immunized animals
(Carmen and Jermutus, 2002). Second, large numbers of
phage antibodies can be screened rapidly, in some cases using
high-throughput methods (Winter et al., 1994). Third, during
phage library construction, the heavy chain variable regions
(VH) and light chain variable regions (VL) of individual B cells
are randomly reassorted to create unique antibodies that
were not present in the immune repertoire of the donor
animal. In this manner, phage display can yield antibodies
speciﬁc for epitopes that might not have generated mono-
clonal antibodies due to tolerance as well as antibodies
against antigens that are too toxic to use as immunogens.
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strategies. The ﬁrst involves screening non-immune phage
libraries. Non-immune libraries are typically highly complex
(109–1011 clones), consistingof scFvs formed from theVH andVL
fragments of a large number of naïve donor animals or humans
(Sheets et al., 1998; Huie et al., 2001; Amersdorfer et al., 2002;
Carmen and Jermutus, 2002). The advantage of this strategy is
that a single highly complex library can be used to screen for
many different targets. The disadvantages of this strategy are
that the frequency of scFvs speciﬁc for a given Ag are low,
thereby necessitating a large amount of screening, and that the
afﬁnity of the scFvs identiﬁed are often only moderate, making
it necessary to employafﬁnitymaturation throughmutagenesis
to achieve the required afﬁnity (Kontermann and Dubel, 2001;
Amersdorfer et al., 2002). The alternative strategy is to screen
immune libraries, which are generated from the B cells of
immunized animals or humans after an infection. Immune
libraries are typically smaller (105–106 clones) than non-
immune libraries but usually contain a much higher frequency
of scFvs that bind with high afﬁnity to the Ag used for
immunization. For this reason, immune libraries typically
yield a greater number of candidate scFvs than non-immune
libraries. The disadvantage of using immune libraries is that a
new librarymust beused foreach target Ag. This involvesboth a
dedicated series of immunized animals or patient samples and
the effort required for library construction itself.
The utility of immune phage display antibody libraries
would be improved if they could be used to obtain antibodies
against multiple distinct target antigens. We hypothesized
that, due to the reassortment of VH and VL regions, an immune
library generated against one antigen would contain scFvs
that recognize members of the same protein family at a
reasonable frequency and thereby eliminate the need to
generate immune libraries for each family member. Here, we
tested this hypothesis by mining an existing anti-human Toll-
like receptor-2 (hTLR2) library for scFvs that are speciﬁc for
other members of the Toll-like receptor (TLR) family. TLRs are
important mediators of innate immune response, but inves-
tigation of these receptors has been hampered by a lack of
antibodies capable of binding to cell surface TLRs. Anti-TLR
antibody generation has proven problematic because TLRs
can be difﬁcult to express as recombinant proteins and
because antibodies raised against TLR proteins often fail to
recognize these proteins in their native form expressed on the
cell surface (Lipes et al., 2008). In previous workwe addressed
these problems by establishing an entirely cell-based proce-
dure to produce scFvs that bind to native proteins on the
surface of cells (Lipes et al., 2008). This allowed the generation
of numerous scFvs that bind cell-surface hTLR2. In the current
study, we sought to extend the use of our existing anti-TLR2
scFv library by using our cell-based system to select scFvs
speciﬁc for other members of the TLR family from this library.
This strategy, which we refer to as homologmining, proved to
be feasible, as we were able to identify scFvs speciﬁc for
mTLR2, hTLR5, and hTLR6 that did not cross-react with the
original immunogen, hTLR2. These results demonstrate that a
single immune library can be mined for recombinant Abs
against multiple homologous cell surface proteins using a
procedure that efﬁciently selects for scFvs that bind those
proteins in their native form. This strategy should extend the
utility of existing immune phage display libraries and providea marked increase in the efﬁciency with which Abs against
families of complex cell surface proteins can be generated.
2. Materials and methods
2.1. TLR expression constructs and cell lines
mTLR2-HA-pUNO and hTLR2-HA-pUNO plasmids were
purchased from InvivoGen (San Diego, CA). The 300.19 mouse
tumor cell line (Kearney et al., 1979) (kindly provided by Dr. T.
Tedder, Duke University, Durham, NC) was transfected with
hTLR2-HA-pUNO by electroporation and used for immuniza-
tions. For library selection and ﬂow cytometry assays, HEK293
cells (ATCC, Manassas, VA) were transfected with hTLR2-HA-
pUNO or mTLR2-HA-pUNO using Superfect (Quiagen, Valen-
cia, CA). hTLR1-HA-pUNO, hTLR5-HA-pUNO, and hTLR6-HA-
pUNO transfected HEK cells were purchased from InvivoGen.
The term TLR-HEK used in the following sections refers to all
mTLR2, hTLR1, hTLR5, and hTLR6-HEKs, unless otherwise
noted. Expression of TLRs was veriﬁed by probing Western
blots of cell extracts with anti-HA antibody. The YFP-HEK cells
for TLR-negative controls were kindly provided by Dr. R.
Lefkowitz (Duke University).
2.2. scFv library panning by cell-based selection
Construction of the anti-hTLR2 immune phage library was
described previously (Lipes et al., 2008). Panning of this library
was performed using the biopanning and rapid analysis of
selected interactive ligand (BRASIL) approach (Giordano et al.,
2001) with slight modiﬁcations. All solutions and incubations
were at 4 °C unless otherwise noted. HEK293 and TLR-HEK cells
were harvested with Versene (Invitrogen, Carlsbad, CA),
washed in Dulbecco's PBS and resuspended at 107 cells/ml in
DMEM (Invitrogen)/ 1% BSA Fraction V (Sigma, St. Louis, MO).
An aliquot of anti-hTLR2 scFv phage library containing 5×109
M13 phage particles was added to 150 μl of HEK293 cells
suspension and rotated for 2 h. This solutionwas layered on top
of 200 μl of a mixture of dibutyl phthalate:cyclohexane (15/1)
(Sigma) and spun at 10,000 g in a microfuge for 10 min. The
aqueous phase containing pre-cleared phage was used to
resuspend a cell pellet containing 1.5×106 TLR-HEK cells. This
suspension was rotated for 1.5 h. The cells were washed three
times in 200 μl DMEM/1% BSA, then resuspended in 200 μl
DMEM/1% BSA and layered over 200 μl of dibutyl phthalate:
cyclohexane (15/1). After centrifugation (10,000 g×10min), the
tube was ﬂash frozen in liquid nitrogen. The cell pellet with
bound phage in the tube tip was removed with a tube cutter
(GeneMate). The cell pellet was resuspended in 10 ml of log-
phase TG-1 cells. Following a 30 min incubation at 37 °C, the
cells were concentrated by centrifugation and plated on two
15 cm 2xYT/AG plates. The plates were incubated for 16 h at
30 °C. The resulting colonieswere scraped into 2xYTandused to
make a glycerol frozen stock.
2.3. Phage rescue
M13 phage particles for selections and screening were
obtained by rescue with M13K07 phage (New England
Biolabs, Ipswich, MA). To prepare concentrated phage, 12 ml
2xYT/AG (2xYT supplemented with 2% glucose and 0.1 mg/ml
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clones and grown at 37 °C until OD600 reached 0.7. 2×1011
M13K07 helper phage were added and allowed to infect for
30 min at 37 °C then the culture was shaken at 200 rpm for
30 min at 37 °C. Bacteria were pelleted at 3500 g for 10 min
and the medium replaced with 50 ml of 2xYT supplemented
with ampicillin and kanamycin. The culture was shaken at
37 °C for 30 min, then at 30 °C for 16 h. The culture was
centrifuged as above, and the supernatant subjected to
sequential precipitations in 0.2 volumes of ice-cold 20%
PEG-8000/2.5 M NaCl to concentrate the phage particles.
Phage particles were pelleted at 10,000 g for 10 min.
Following the last precipitation, the phage were resuspended
in 1 ml PBS and stored at 4 °C. Phage titers were determined
by infections of TG-1 cells with serially diluted phage.
Individual phage clones were rescued for ﬂow cytometry
screens in sterile 2 ml/ well 96-well plates (Continental Lab
Products, San Diego, CA). Brieﬂy, 400 μl of 2xYT/AG in each
well was inoculated with a phage clone and shaken at
200 rpm for 16 h at 30 °C. Aliquots from the wells of this
master plate were used to inoculate a rescue plate containing
400 μl of 2xYT/AG supplemented with 2×1010 phage/ml of
M13K07 helper phage. The rescue plate was shaken at 37 °C
for 4 h. After centrifugation (3000 g, 10 min), bacteria pellets
were resuspended in 400 μl of 2xYT/AK and shaken for 16 h at
30 °C. The plate was centrifuged again as above to pellet
bacteria and the supernatant containing phage particles was
transferred to a fresh plate for screening assays.
2.4. Flow cytometric screening and clone validation
Procedures for phage clone screening and phage and
puriﬁed scFv binding assays were performed as previously
described (Lipes et al., 2008). Brieﬂy, TLR-HEK and YFP-HEK
were mixed in equal numbers, plated in 96-well U-bottom
plates at 5×105 cells/well, stained with phage or scFv
preparations as primary reagents, washed, stained with
secondary and tertiary reagents, and subjected to ﬂow
cytometric analysis using a BD LSRII ﬂow cytometer. Data
were analyzed using Flowjo software (TrecStar Inc, Ashland,
OR). To determine TLR-speciﬁc binding, TLR-HEK and YFP-
HEK cell populations were gated separately based on YFP
ﬂuorescence in the FITC channel, and the mean ﬂuorescence
intensity (MFI) of allophycocyanin (APC) was determined for
each population. TLR-speciﬁc staining was calculated as the
TLR-HEK MFI minus the YFP-HEK MFI of APC. Staining of cells
with puriﬁed biotinylated scFvs was performed on mTLR2-
HEK, J774A.1 (Ralph and Nakoinz, 1977b) cells, and mouseTable 1
Summary of numbers of clones and positive rates for screening/veriﬁcation at each
Screened by Initial screen–raw phage Fingerp
# of clones screened # of clones positive # of un
hTLR2 HEK 168 78 (46%) 9/23 (3
mTLR2-HEK 84 43 (51%) 18/32 (
hTLR5-HEK R3 186 39 (21%) 18/39 (
R4⁎ 92 22 (24%) 2/19 (1
hTLR6-HEK 186 11 (6%) 6/8 (75
hTLR1-HEK 94 0 (0%) N/A
Numbers in fractions indicate “number of positive clones/number of clones tested”
⁎ Results after performing a 4th round of selection (R4) for hTLR5 versus the standlung cells (see below). The staining procedure was as above
except the staining buffer contained 5% normal mouse serum
and 5% normal rat serum. 1 μg/ml biotinylated scFvs were
used as the primary staining reagent, and 0.2 μg/ml
allophycocyanin-conjugated streptavidin (BD Biosciences,
San Jose, CA) was used as the secondary staining reagent.
2.5. DNA ﬁngerprinting
ScFv inserts obtainedby PCR from infected bacteria (Gussow
and Clackson, 1989) were subjected to restriction fragment
length polymorphism or “DNA ﬁngerprint” analysis. PCR was
performed using 2 μl of TG-1 culture, 200 μM dNTPs, 200 μM
pCANTAB 5E primers (scFvGWfwd: GCGGCCCAGCCGGCC;
scFvGWrev: CTGGAACCGCGTG), 3 units EasyADNA polymerase
(Stratagene, La Jolla, CA), and manufacturer's buffer in 50 μl.
After ampliﬁcation (95 °C for 2 min, 30 cycles of 95 °C×30 s,
58 °C for 30 s, 72 °C for 1 min; and 72 °C for 10min), aliquots of
the productwere digestedwith Sau3A I or BstN I (New England
Biolabs) then fractionated on 2% agarose TAE gels.
2.6. Expression of soluble scFvs in Drosophila
ScFv inserts were ampliﬁed from pCANTAB 5E (GE Life
Sciences, Buckinghamshire, UK) using above PCR conditions
and ligated with topoisomerase into the Gateway entry vector
pCR8Topo (Invitrogen). The Drosophila expression vector
pMTBiP/V5His (Invitrogen) was converted to a Gateway
destination vector by replacing the multiple cloning sequence
with recombination sites for the bacteriophage enzyme LRII
(Invitrogen) and a BirA Avitag site (Avidity, Denver, CO). After
recombining scFv inserts into pMTBiP, the resulting plasmids
and pCoBlast (Invitrogen) were co-transfected into Schneider 2
(S2) cells using Cellfectin (Invitrogen) and selected in 25mg/ml
blasticidin to obtain stable tranfectants. ScFv expression was
induced with 0.75 mM CuSO4 in Sf900-II serum-free medium
(Invitrogen) for 36 to 48 h at 28 °C. ScFvs were puriﬁed from
culture supernatant by ion metal afﬁnity chromatography
(Talon resin, Clontech, Mountain View, CA), and subjected to
SDS-PAGE with silver staining and BCA assay (Pierce, Rockford,
IL) to assess purity and quantity. To make biotinylated-scFvs,
puriﬁed scFvs were subject to in vitro BirA biotinylation
(Avidity) as described in manufacture's instructions.
2.7. Primary mouse lung cells
8–12 week-old C57BL/6 mice received 12.5 μg LPS
intranasally and lung parenchymal cells were harvestedstep of anti-TLR scFv generation
rint Puriﬁed phage binding to cells scFv binding to cells
ique clones # of clones positive # of clones positive
9%) 8/9 (89%) 5/5 (100%)
56%) 5/9 (56%) 5/5 (100%)
46%) 2/17 (12%) 1/2 (50%)
1%) 1/2 (50%) 1/2 (50%)
%) 1/6 (17%) 1/1 (100%)
N/A N/A
and percentages in parentheses indicate positive rates for each test.
ard 3 rounds (R3) of selection.
Fig. 1. Identiﬁcation and characterization of anti-mTLR2 antibody clones. (A) Screening anti-mTLR2 antibody clones. Raw phage preparations of individual clone
were used to stain mTLR2-HEK (white) or YFP-HEK (gray) cells. 20 representative clones are shown here. Positive clones are indicated in bold. (B) Validation of anti-
mTLR2 binding. Puriﬁed phage (left) or corresponding scFvs (center) were used as primary Ab to stain on mTLR2-HEK cells (white) or YFP-HEK (gray). Right panel
shows J774A.1 cells stained with anti-mTLR2 scFvs (white) or with anti-Tie2 scFv (gray). (C) mTLR2-scFv bind to primarymouse lung cells. Puriﬁed anti-mTLR2 scFv
was used as primary Ab to stain mouse lung cells (white). In the left panel, anti-Tie2 antibody was used as a negative control antibody (gray). In the right panel, cells
harvested from amTLR2 konck-out mouse were used as negative control cells (gray). Lungs were harvested from intranasally LPS-treated mouse and myeloid cells
populations were identiﬁed as described by Lin et al.
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lungs were perfused with 3 ml HBSS, minced and digested
with 1 mg/ml of collagenase for 40 min at 37 °C. Cells weredissociated by passing through a 70-μm mesh strainer.
Dendritic cells (DC) and macrophages were enriched by
passing through a 17% Metrizamide gradient at room
148 Y.-H. Chen et al. / Journal of Immunological Methods 340 (2009) 144–153temperature. Red blood cells were lysed using AKC buffer
(0.15 M NH4Cl, 10 mM KHCO3, 0.1 mM EDTA, pH7.2–7.4). The
resulting single cell suspensions were subjected to staining
and ﬂow cytometry analysis to identify neutrophils, DC,
macrophages, and monocytes as described (Lin et al., 2008).
3. Results
3.1. Library enrichment and antibody clone screening against
murine TLR2
To determine the feasibility of obtaining scFvs against
hTLR2 homologs from an anti-hTLR2 library, we used the
library, selection, and screening procedures we have pre-
viously described (Lipes et al., 2008). In brief, multiple BALB/c
and C57BL/6 mice were immunized with hTLR2-transfected
300.19 cells and relative anti-hTLR2 IgG sera titers deter-
mined in a ﬂow cytometric assay. High titer animals were
used to construct an anti-hTLR2 M13 phage-scFv library,
which had a theoretical complexity of 3×106. To enrich for
clones speciﬁc for TLRs other than hTLR2, we employed a cell-
based selection procedure, BRASIL, which relies on differen-
tial centrifugation to obtain Ag-speciﬁc phage clones (Gior-
dano et al., 2001). In this procedure, the scFv phage library is
ﬁrst pre-cleared over parental HEK293 cells, subjected to
differential centrifugation, and then the remaining phage in
the supernatant are incubated with target TLR-HEK cells.
Another differential centrifugation through an organic phase
removes loosely associated non-speciﬁc phage. The phage
remaining bound to TLR-HEK cells are then used to generate
enriched phage stocks for iterative rounds of selections. Once
enriched, the phage library is arrayed as individual clones in
96 well plates. The raw phage preparations, in plates, are
screened for their ability to bind target (TLR-HEK) but not
control (YFP-HEK) cells in a high throughput ﬂow cytometric
assay. The resulting positive clones are subjected to restriction
fragment length polymorphism or “DNA ﬁngerprint” analysis
to eliminate duplicates, prepared as puriﬁed phage, and
tested again by ﬂow cytometry to conﬁrm their speciﬁc
binding to TLR-HEK cells. The scFv inserts of conﬁrmed clones
are subcloned into a Drosophila expression vector, expressed
as soluble scFvs in Schneider 2 (S2) cells, puriﬁed, biotiny-
lated, and validated for their ability to speciﬁcally bind TLR-
HEK cells in a ﬂow cytometric assay.
To test homologmining, we ﬁrst attempted to identify clones
speciﬁc for mTLR2, the receptor most closely related to hTLR2.
The hTLR2 scFv library was subjected to three iterative rounds of
BRASIL selection usingmTLR2-HEK cells for positive selection. 43
(51%) of the 84 clones screened in a ﬂow cytometric assay were
positive for mTLR2 binding (Table 1, Fig. 1A). DNA ﬁngerprinting
of32clones revealed18 (56%) tobeunique (Table1).Nineof these
unique clones were used to generate puriﬁed phage stocks and
tested for their ability to bind mTLR2. Five (56%) of these nine
anti-mTLR2 phage clones proved to be positive in this con-Fig. 2. Identiﬁcation of anti-hTLR5 or anti-hTLR6 antibody clones. (A and B) Screening a
preparationwere used as primary Ab to stain hTLR5- (A, white), hTLR6- (B, white), or Y
clones are indicated in bold. (C and D) Flow cytometry staining results for two represe
puriﬁed phage (center), or puriﬁed scFvs (right) were used as primary antibody to staﬁrmatory test (Table 1, Fig. 1B), and were subcloned and
expressed as puriﬁed soluble scFvs in S2 cells. All ﬁve clones
retained their capacity to speciﬁcally bind to mTLR2-HEK cells
when expressed as soluble scFvs (Table 1, Fig. 1B). Importantly,
none of these anti-mTLR2 clones demonstrated binding to
human TLR2 (Fig. 3 and data not shown).
To determine whether the anti-mTLR2 scFvs identiﬁed
are able to detect endogenous mTLR2, these clones were
tested for their ability to stain a murine monocyte/macro-
phage cell line, J774A.1 (Ralph and Nakoinz, 1977a). Despite
the low level of mTLR2 expression in this cell line, all scFvs
were able to detect mTLR2 on the surface of these cells
(Fig. 1B). One anti-mTLR2 scFv (D2–3) was also tested for its
ability to stain primary lung cells. As shown in Fig. 1C, clone
D2–3 detected expression of mTLR2 on inﬂammatory
monocytes, neutrophils, macrophages, and dendritic cells
obtained from the lungs of LPS-treated mice. No such
staining was seen on cells obtained from TLR2-deﬁcient
mice orwhen stainingwas performedwith an irrelevant scFv
(anti-Tie2 clone ExTek 1D6). These ﬁndings demonstrate that
it is possible to obtain anti-mTLR2 antibodies that have
sufﬁcient afﬁnity to detect endogenous mTLR2 from a library
raised against hTLR2.
3.2. Homolog mining for anti-hTLR1, hTLR5, and hTLR6 scFvs
Having demonstrated that homolog mining works in
principle, we sought to test this procedure with other, less
homologous, members of the TLR family. Separate cell-based
selections of the hTLR2 library were performed as above for
hTLR1, hTLR5 and hTLR6. After 3 rounds of selection, arrays of
the enriched clones were screened in a ﬂow cytometric assay.
These initial screens yielded 39 (21%) of 186 positive clones
for hTLR5 and 11 (6%) of 186 positive clones for hTLR6 (Table 1,
Fig. 2A and B). No positive clones were obtained for hTLR1
from a screen of 94 clones (Table 1). After elimination of
duplicate clones by DNA ﬁngerprinting (Table 1), the activity
of clones prepared as puriﬁed phagewas validated for binding
to the selected TLR.When tested by ﬂow cytometry, 2 (12%) of
17 anti-hTLR5 phage clones and 1 (17%) of 6 anti-TLR6 clones
bound their respective target (Fig. 2C, D and Table 1). Without
antibodies available to use as a positive controls in screening
hTLR5 and hTLR6, it was more difﬁcult to distinguish positive
clones from background signals (Fig. 2A, B and data not
shown) than it was for previous TLR2 measurements that
included a positive control. This resulted in a higher rate of
false positives for hTLR5 and hTLR6. When prepared as
puriﬁed scFvs in Drosophila cells, 1 out of 2 (50%) anti-TLR5
scFvs bound to hTLR5-HEK cells, while 1 out of 1 (100%) anti-
hTLR6 scFvs bound to hTLR6-HEK cells (Fig. 2C, D and Table 1).
In an attempt to obtain more anti-hTLR5 clones, we
performed a fourth round of BRASIL selection for hTLR5.
This resulted in similar frequency of positive clones in the
initial screening step (22 out of 92, or 24%), but a much lowernti-hTLR5 (A) or anti-hTLR6 (B) antibody clones. Individual clones of raw phage
FP- (A and B, gray) HEK cells. 20 representative cloneswere shownhere. Positive
ntative hTLR5 (C) or hTLR6 (D) antibody clones. Raw phage preparations (left)
in hTLR5- (C, white) , hTLR6- (D, white) or YFP- (gray) HEK cells.,
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Fig. 3. Anti-TLR antibody clones speciﬁcally bind their target Ag but not other TLRs. scFvs against hTLR2 (clone B11), hTLR5 (clone 3B5), hTLR6 (clone 3F7), mTLR2
(clone B2–3), or Tie2 extra-cellular domain (ExTek, clone 1D6) were used as primary antibodies to stain hTLR1-, hTLR2-, hTLR4-, hTLR5-, hTLR6-, mTLR2- ormTLR5-
HEK (white), with YFP-HEK as negative control cells (gray). All scFv clones obtained to date show the same speciﬁcity to their target TLR Ag and the result of one
representative clone is shown here for each group. Positive stainings are outlined in bold.
150 Y.-H. Chen et al. / Journal of Immunological Methods 340 (2009) 144–153frequency of unique clones (2 out of 19, or 11%) than seen after
three rounds of selection (Table 1, hTLR5-HEK R4).
3.3. Speciﬁcity of TLR scFv clones
A potential pitfall of homolog mining is that it may select
for scFvs that bind to protein domains conserved among
multiple receptors and thereby only identify clones that
cross-react with multiple TLRs. To ensure that the scFvs we
identiﬁed are speciﬁc to individual TLRs, we examined the
binding of puriﬁed anti-TLR scFvs mined from the hTLR2
library to all of the TLRs we have expressed. The anti-Tie2
scFv, ExTek clone 1D6, was again used as negative control. As
shown in Fig. 3, all of the scFv clones we identiﬁed bound only
to their target and displayed no cross-reactivity to other
members of the TLR family. In the case of TLR2, scFvs
demonstrated no cross-species reactivity. The anti-TLR scFvs
isolated from the hTLR2 library thus exhibit exquisite
speciﬁcity for their target TLR. This result suggests that
homolog mining selects for scFvs that recognize epitopes that
are not fully conserved among TLRs.3.4. Origin of anti-homolog scFvs
As shown above, our scFv phage display library, which
was raised against hTLR2, contains clones speciﬁc for TLRs
other than hTLR2. It is not clear if such clones represent
antibody molecules formed in vivo after immunization
or if they were created during library construction in the
course of VH–VL re-assortment. To address this question, we
examined the reactivity of the sera of the individual hTLR2-
immunized mice used to construct the phage library. Using a
ﬂow cytometric assay we have previously described (Lipes
et al., 2008), serial dilutions of each serum sample were
tested for binding to hTLR1, hTLR2, mTLR2, hTLR5, and
hTLR6.
As we have shownpreviously (Lipes et al., 2008), sera from
responsive hTLR2-immunized mice contain detectable anti-
TLR2 antibodies at dilutions up to 212 (Fig. 4). In contrast, the
reactivity of these sera against hTLR1, mTLR2, hTLR5 and
hTLR6 is no greater than that of unimmunized mice (Fig. 4).
Antibodies against these TLRs are either not present in the
original antibody repertoire or represent an extremely small
Fig. 4. Sera from hTLR2-immunized mice does not contain detectable levels
of IgG against hTLR1, hTLR5, hTLR6 or mTLR2. Mice were immunized with
hTLR2 by a cell-based immunization method and sera were harvested 7 days
after the 5th boost. Mice sera were used as primary staining reagents in ﬂow
cytometry to test their binding on hTLR2-, mTLR2-, hTLR5-, hTLR6- or hTLR1-
HEK, respectively. Ag-speciﬁc IgG titer was detected by secondary staining of
APC-conjugated goat-anti-mouse IgG antibody. Serum from naïve mice were
used as negative control.
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identiﬁed are the products of combinatorial re-assortment of
heavy and light chain variable fragments.
4. Discussion
The screening of immune scFv phage display libraries is an
effective means to generate large numbers of high afﬁnity
single-chain antibodies against a single antigen. The major
impediment to the routine use of this strategy has been the
need to construct a new library for each individual antigenic
target. Here, we demonstrate that a novel strategy, homolog
mining, can be used to signiﬁcantly extend the utility of
immune scFv libraries. By homolog mining an existing anti-
hTLR2 library, we were able to obtain scFvs speciﬁc for three
of the four hTLR2 homologs we targeted. These results
demonstrate that, although not foolproof, homolog mining
has the potential to markedly reduce the number of libraries
required to generate antibodies against a family of proteins. It
appears that homolog mining is widely applicable. Prelimin-
ary results in our lab indicate that an anti-Tie2 scFv library can
be mined for antibodies against other receptor tyrosine
kinases (Lipes and Kenan, manuscript in preparation).
Our ﬁndings demonstrate that a signiﬁcant number of
anti-homolog scFvs are present in our immune library. These
were most likely generated via the combinatorial re-assort-
ment of anti-hTLR2, and perhaps background, VH and VLfragments during library construction. Consistent with this
view, we were unable to detect anti-homolog binding activity
in the sera of the mice used for library construction. We have
no way to assess the extent to which reassortment increased
the diversity and complexity of our library over that from the
cells from which it was derived. However, previous studies
suggest that this increase can be signiﬁcant. In one elegant
study, transgenic mice were engineered to express a single
immunoglobulin mu heavy chain derived from a vesicular
stomatitis virus Indiana serotype-neutralizing (VSV-Ind) anti-
body (Senn et al., 2003). This heavy chain could not undergo
rearrangements and was expressed in combination with
endogenous kappa or lambda chains. The mice expressed a
B cell repertoire biased heavily toward VSV-Ind, with 30 to
60% of the peripheral B cells showing VSV-Ind speciﬁcity.
Despite this bias, the mice were able to mount successful B
cell responses when immunized with the VSV-New Jersey
serotype virus as well as other unrelated antigens such as
bacterial porins. These studies showed combinatorial L chain
variability alone is capable of generating a complex antibody
repertoire. In another study, induction of further VH and VL re-
assortment with Cre recombinase in a naive scFv library
increased its calculated theoretical complexity from 107 to
1011 (Sblattero and Bradbury, 2000; Cen et al., 2006).
When this library was used in selections for 18 recombinant
targets, an average of 6 speciﬁc antibodies were obtained per
target.
By comparison, even though the number of antibodies
contained inouranti-hTLR2 scFv library (3×106) isﬁveorders of
magnitude lower than the Cre-reassorted library and three to
four orders ofmagnitude lower than the number contained in a
highly complex non-immune library (Sheets et al., 1998;
Carmen and Jermutus, 2002), we were able to obtain multiple
speciﬁc phage clones for most targets by screening a single 96-
well plate. This ﬁnding suggests that immunizationwith hTLR2
provides numerous afﬁnitymatured VH and VL regions directed
at TLRepitopes that,when re-assorted, canbindTLRs other than
the original immunogen. It would be reasonable to expect that
scFvs generated by such re-assortment and selected against a
homolog would bind to both the homolog and the original
immunogen. However, all of the Abs generated from these
selections bound only to their target TLR without cross-
reactivity to the library immunogen hTLR2 or any other TLRs
tested (Fig. 3) antigens. One possible explanation for this is that
the entirely cell-based techniques for selection and screening
employed here allowed the receptors to be fully post-
translationally modiﬁed and to adopt their native, membrane
bound structures, emphasizing subtle structural differences
between homologs. Puriﬁed recombinant proteins often lack
such post-translational modiﬁcations, do not fold into their
native structures, and may have normally internal epitopes
exposed. Homologous domains may therefore adopt more
similar structures in these conditions, thereby increasing the
potential for antibody cross-reactivity. In selections we have
previously performed using recombinant hTLR2 protein, we
saw appreciable cross-reactivity with recombinant hTLR4
protein (data not shown), suggesting that cell-based methods
offer improved antibody speciﬁcity. The impressive level of
speciﬁcity exhibited by our anti-TLR antibodies establishes the
feasibility of using existing immune libraries for selectionswith
related antigens, and suggests that cell-based selectionsmay, in
152 Y.-H. Chen et al. / Journal of Immunological Methods 340 (2009) 144–153general, yield fewer cross-reactive antibodies than selections
with recombinant proteins.
There are several practical aspects of homologmining and
scFv generation that should be emphasized. First, we have
found that the ability to generate scFvs that bind to either the
immunogen or its homologs is highly dependent on the
initial response to immunization. In our hands, libraries
generated frommice that display only low-titer responses to
the immunogen have failed to generate functional scFvs.
Second, the hTLR2 scFv library used in these studies was
constructed by pooling material from six mice of two
different strains. We believe that the strategy of incorporat-
ing multiple immune responses frommultiple mouse strains
into the library captures a more diverse antibody repertoire
thanwould be obtained from a single animal ormouse strain.
A similar approach has been used to harvest immune
responses from patients with autoimmune diseases (de
Wildt et al., 1996) and from convalescent serum (Marks and
Winter, 1992; Amersdorfer et al., 2002) to make human
immune libraries.
Another practical concern is determining the threshold at
which anti-homolog clones are considered positive in initial
screens and, thereby, the sensitivity and speciﬁcity of this
assay. In instances where a control antibody is not available,
setting this threshold correctly can be problematic. In
addition, the concentration of phage in the raw phage
preparations used for screening can vary markedly between
wells, leading to large differences in signal that are indepen-
dent of the actual binding afﬁnity. The relatively high level of
background staining seen in our anti-TLR5 and anti-TLR6
screens was likely due to a low level of expression of these
TLRs on HEK cells, and perhaps a lower afﬁnity of the scFvs
speciﬁc for these TLRs. Thus, the high rate of false positives
seen in these screens is not a general feature for this
technique, but will depend on scFv afﬁnities, target expres-
sion levels, and the criteria determined by the user to select
positive clones.
In order to be certain our TLR positive clones were
emerging as the result of successful enrichment through our
cell-based selections, we screened the original library without
enrichment as well as pools of phage resulting from only two
rounds of enrichment. No phage clones binding to any TLRs
were seen in either instance (data not shown). A fourth round
of selection performed for some of the receptors did not yield
a more enriched population, but rather a much less diverse
pool of positive clones (Table 1, hTLR5-HEK R4 and data not
shown) as well as a distinct population of WT-HEK binding
clones (data not shown). Thus, three rounds of enrichment
were required and optimal to obtain positive clones. Taken
together, these results indicate the anti-mTLR2, -hTLR5, and -
hTLR6 antibody clones generated were not random results of
large scale screening of the anti-hTLR2 library.
The exception to our successful screening results was the
hTLR1 selection, in which we did not discover any anti-hTLR1
antibodies among the 94 clones screened. A more exhaustive
screen may have revealed some positive clones but the more
likely explanation is that a low level of hTLR1 expression in the
cells used for panning may have not permitted sufﬁcient
enrichment during iterative selection. Western blot measure-
ments showed that expression of hTLR1 in HEK cells was lower
than thatof theother TLRHEKcell linesutilized (datanot shown).While these studies illustrate a valuable new application
for immune antibody libraries, highly complex non-immune
antibody libraries remain the best option to obtain antibodies
to the widest variety of targets, particularly antigens that are
non-immunogenic due to tolerance or agents that are too
toxic to use for immunizations (Nowakowski et al., 2002).
However, construction of non-immune libraries is difﬁcult,
requiring extensive reagent optimization to obtain vast
amounts of variable region fragments and necessitating
hundreds of electroporations. Thus, investigators without
access to a non-immune library may wish to instead attempt
selections using an immune library against an antigen related
to their target of interest.
Acknowledgements
We thank John Whitesides, Patti McDermott, and Danielle
King of Duke Human Vaccine Institute Flow Cytometry facility
for their excellent technical assistance. This work was sup-
ported by NIH grant U19-AI056572.
References
Amersdorfer, P., Wong, C., Smith, T., Chen, S., Deshpande, S., Sheridan, R.,
Marks, J.D., 2002. Genetic and immunological comparison of anti-
botulinum type A antibodies from immune and non-immune human
phage libraries. Vaccine 20, 1640.
Carmen, S., Jermutus, L., 2002. Concepts in antibody phage display. Brief
Funct Genomic Proteomic 1, 189.
Cen, X., Bi, Q., Zhu, S., 2006. Construction of a large phage display antibody
library by in vitro package and in vivo recombination. Appl Microbiol
Biotechnol 71, 767.
deWildt, R.M., Finnern, R., Ouwehand,W.H., Grifﬁths, A.D., van Venrooij, W.J.,
Hoet, R.M., 1996. Characterization of human variable domain antibody
fragments against the U1 RNA-associated A protein, selected from a
synthetic and patient-derived combinatorial V gene library. Eur J
Immunol 26, 629.
Giordano, R.J., Cardo-Vila, M., Lahdenranta, J., Pasqualini, R., Arap, W., 2001.
Biopanning and rapid analysis of selective interactive ligands. Nat Med 7,
1249.
Gussow, D., Clackson, T., 1989. Direct clone characterization from plaques and
colonies by the polymerase chain reaction. Nucleic Acids Res 17, 4000.
Huie, M.A., Cheung, M.C., Muench, M.O., Becerril, B., Kan, Y.W., Marks, J.D.,
2001. Antibodies to human fetal erythroid cells from a nonimmune
phage antibody library. Proc Natl Acad Sci U S A 98, 2682.
Kearney, J.F., Radbruch, A., Liesegang, B., Rajewsky, K., 1979. A new mouse
myeloma cell line that has lost immunoglobulin expression but permits
the construction of antibody-secreting hybrid cell lines. J Immunol 123,
1548.
Kohler, G., Milstein, C., 1975. Continuous cultures of fused cells secreting
antibody of predeﬁned speciﬁcity. Nature 256, 495.
Kontermann, R., Dubel, S., 2001. Antibody Engineering. Springer, New York.
Lin, K.L., Suzuki, Y., Nakano, H., Ramsburg, E., Gunn, M.D., 2008. CCR2+
monocyte-derived dendritic cells and exudate macrophages produce
inﬂuenza-inducedpulmonary immunepathologyandmortality. J Immunol
180, 2562.
Lipes, B.D., Chen, Y.-H., Ma, H., Staats, H.F., Kenan, D.J., Gunn, M.D., 2008. An
entirely cell-based system to generate single-chain antibodies against
cell surface receptors. J Mol Biol 379, 261.
Marks, J.D.,Winter, G.,1992. An artiﬁcial immune system formaking antibodies.
Behring-Inst -Mitt 6.
Marks, C., Marks, J.D., 1996. Phage libraries–a new route to clinically useful
antibodies. N Engl J Med 335, 730.
McCafferty, D.P., Grifﬁths, A.D., Winter, G., Chiswell, D.J., 1990. Phage
antibodies: ﬁlamentous phage displaying antibody variable fragments.
Nature 348, 552.
Nowakowski, A., Wang, C., Powers, D.B., Amersdorfer, P., Smith, T.J.,
Montgomery, V.A., Sheridan, R., Blake, R., Smith, L.A., Marks, J.D., 2002.
Potent neutralization of botulinum neurotoxin by recombinant oligoclo-
nal antibody. Proc Natl Acad Sci U S A. 99, 11346.
Ralph, P., Nakoinz, I., 1977a. Antibody-dependent killing of erythrocyte and
tumor targets by macrophage-related cell lines: enhancement by PPD
and LPS. J Immunol 119, 950.
153Y.-H. Chen et al. / Journal of Immunological Methods 340 (2009) 144–153Ralph, P., Nakoinz, I., 1977b. Direct toxic effects of immunopotentiators on
monocytic, myelomonocytic, and histiocytic or macrophage tumor cells
in culture. Cancer Res 37, 546.
Sblattero, D., Bradbury, A., 2000. Exploiting recombination in single bacteria
to make large phage antibody libraries. Nat Biotechnol 18, 75.
Senn, B.M., Lopez-Macias, C., Kalinke, U., Lamarre, A., Isibasi, A., Zinkernagel,
R.M., Hengartner, H., 2003. Combinatorial immunoglobulin light chain
variability creates sufﬁcient B cell diversity to mount protective antibody
responses against pathogen infections. Eur J Immunol 33, 950.Sheets, M.D., Amersdorfer, P., Finnern, R., Sargent, P., Lindqvist, E., Schier, R.,
Hemingsen, G., Wong, C., Gerhart, J.C., Marks, J.D., 1998. Efﬁcient
construction of a large nonimmune phage antibody library: the
production of high-afﬁnity human single-chain antibodies to protein
antigens. Proc Natl Acad Sci U S A. 95, 6157.
Winter, G., Grifﬁths, A.D., Hawkins, R.E., Hoogenboom, H.R., 1994. Making
antibodies by phage display technology. Annu Rev Immunol 12, 433.
